RYAN MANSI: Open Payments
NPI 1558986174 · NORWICH, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,667 in 62 payments from 17 companies in 2025. Trend: 2023 $1,041 · 2024 $1,433 · 2025 $1,667
Food & beverage: $1,667
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 8 | $313 |
| SK Life Science, Inc. | 10 | $282 |
| ABBVIE INC. | 11 | $239 |
| Axsome Therapeutics, Inc. | 1 | $121 |
| Lundbeck LLC | 5 | $114 |
| Alexion Pharmaceuticals, Inc. | 5 | $100 |
| Lilly USA, LLC | 4 | $92 |
| PFIZER INC. | 4 | $89 |
| Neurelis, Inc. | 3 | $77 |
| Octapharma USA, Inc. | 3 | $76 |
Products named: Fintepla, BOTOX, Symbravo, VYEPTI, ULTOMIRIS, QULIPTA, KISUNLA, VALTOCO.
Industry payments across CT — which companies pay providers there.
